The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Abstract
PURPOSE: This is the initial report from the health-related quality of life (HRQL) component of the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. This report provides an overview of HRQL findings, comparing tamoxifen and placebo groups, and advice to clinicians counseling women about the use of tamoxifen in a prevention setting. PATIENTS AND METHODS: This report covers the baseline and the first 36 months of follow-up data on 11,064 women recruited over the first 24 months of the study. Findings are presented from the Center for Epidemiological Studies–Depression Scale (CES-D), the Medical Outcomes Study 36-Item Short Form Health Status Survey (MOS SF-36) and sexual functioning scale, and a symptom checklist. RESULTS: No differences were found between placebo and tamoxifen groups for the proportion of participants scoring above a clinically significant level on the CES-D. No differences were found between groups for the MOS SF-36 summary physical and mental scores. The mean number of symptoms reported was consistently higher in the tamoxifen group and was associated with vasomotor and gynecologic symptoms. Significant increases were found in the proportion of women on tamoxifen reporting problems of sexual functioning at a definite or serious level, although overall rates of sexual activity remained similar. CONCLUSION: Women need to be informed of the increased frequency of vasomotor and gynecologic symptoms and problems of sexual functioning associated with tamoxifen use. Weight gain and depression, two clinical problems anecdotally associated with tamoxifen treatment, were not increased in frequency in this trial in healthy women, which is good news that also needs to be communicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Self-citationRobins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
Fisher, B., Anderson, S., Redmond, C. K., Wolmark, N., Wickerham, D. L., & Cronin, W. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332203 · Cited by 1,465
Self-citationFisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,464
Self-citationFisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., Cronin, W. M., & Contributors, O. N. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.527 · Cited by 1,268
Self-citationFisher, B., Dignam, J., Bryant, J., DeCillis, A., Wickerham, D. L., Wolmark, N., Costantino, J., Redmond, C., Fisher, E. R., Bowman, D. M., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1529 · Cited by 861
Self-citationThe Center for Epidemiologic Studies Depression Scale: its use in a community sample
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.1.41 · Cited by 804
Development of a Brief Screening Instrument for Detecting Depressive Disorders
Burnam, M. A., Wells, K. B., Leake, B., & Landsverk, J. (1988) · Medical Care · doi:10.1097/00005650-198808000-00004 · Cited by 501
Symptoms Associated With Tamoxifen Treatment in Postmenopausal Women
Love, R. R. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400090120021 · Cited by 273
Ganz, P. A., Day, R., Ware, J. E., Redmond, C., & Fisher, B. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1372 · Cited by 206
Self-citationMoredo Anelli, T. F., Anelli, A., Tran, K. N., Lebwohl, D. E., & Borgen, P. I. (1994) · Cancer · doi:10.1002/1097-0142(19940701)74:1<74::aid-cncr2820740113>3.0.co;2-# · Cited by 180
Long-term tamoxifen citrate use and potential ocular toxicity
Gorin, M. B., Day, R., Costantino, J. P., Fisher, B., Redmond, C. K., Wickerham, D. L., Gomolin, J. E. S., Margolese, R. G., Mathen, M. K., Bowman, D. M., et al. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80190-1 · Cited by 138
Self-citationCathcart, C. K., Jones, S. E., Pumroy, C. S., Peters, G. N., Knox, S. M., & Cheek, J. H. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00665698 · Cited by 77
Fisher, B., & Redmond, C. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405193302015 · Cited by 53
Self-citationShariff, S., Cumming, C. E., LEES, A. W., Handman, M., & Cumming, D. C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31394.x · Cited by 43
Reversible Central Nervous System Dysfunction Due to Tamoxifen in a Patient with Breast Cancer
Pluss, J. L., & DiBELLA, N. J. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-5-652 · Cited by 24
Cited by
Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study
Ganz, P. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.39 · Cited by 1,060
Self-citationSide Effects of Adjuvant Treatment of Breast Cancer
Shapiro, C. L., & Recht, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442607 · Cited by 724
Weight, Weight Gain, and Survival After Breast Cancer Diagnosis
Kroenke, C. H., Chen, W. Y., Rosner, B., & Holmes, M. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.079 · Cited by 670
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment
Ganz, P. A., Greendale, G. A., Petersen, L., Kahn, B., & Bower, J. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.196 · Cited by 533
Self-citation
Metadata
- Authors
- Day, R., Ganz, P. A., Costantino, J. P., Cronin, W. M., Wickerham, D. L., & Fisher, B.
- Venue
- Journal of Clinical Oncology
- Published
- 1999-09
- Volume
- 17
- Issue
- 9
- Pages
- 2659-2659
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2139422964
- Cited by
- 438
- References
- 19
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.